The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Molecular Mechanisms of Dyskinesia in Parkinson's Disease, 2003Mechanisms of Graft-Induced Dyskinesias in an Animal Model of Parkinson's Disease
Embryonic dopamine neurons can be transplanted to the region of the brain that becomes depleted of dopamine in Parkinson's disease (PD). Studies performed in both patients and animal models of PD have...
-
Community Fast Track, 2003Regulation of Dopaminergic Pathways by Eph Family Receptors
Replacing dopaminergic neurons is an attractive alternative in the treatment of Parkinson's disease (PD). However, a successful treatment relies not only on the introduction of new neurons, but also...
-
Community Fast Track, 2002Proactive action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a pre-clinical model model of Parkinson's disease
Recently, in mouse studies the peroxisome proliferator-activated receptor-g (PPARg) agonist pioglitazone was shown to be effective in blocking the substantia nigra (SN) cell loss induced by MPTP in a...
-
MJFF Research Grant, 2002Characterization of Alpha Synuclein in Human Fluids & Brain as a Biomarker for Parkinson's Disease
Dr. Michael Schlossmacher and his colleagues at Brigham and Women's Hospital are looking at levels of the protein alpha-synyclein in the blood as a possible biomarker for PD. Mutations in alpha...
-
The Role of Protein Degradation in Parkinson's Disease, 2002Parkin-Mediated Ubiquitination at the Synapse
Parkinson's disease (PD) involves the death of dopamine neurons in the midbrain and leads to devastating motor and functional impairment. Although treatment is available, its effectiveness diminishes...
-
The Role of Protein Degradation in Parkinson's Disease, 2002Ubiquitin Conjugates in Parkinson's Disease and Dementia with Lewy Bodies
To adapt to the ever-changing environment, the cell has to consistently make new proteins and degrade those that are no longer needed or toxic to the cell. Removal of intracellular proteins is...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.